The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd’s generic version of Mylan NV’s EpiPen for the emergency treatment of allergic reactions.
“Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our long-standing commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval,” FDA Commissioner Scott Gottlieb said.
MORE Nation & World ARTICLES TO READ NEXT ...
TOP STORIES FROM THE GAZETTE
- Hiawatha man charged with three counts of attempted murder
- Cristhian Bahena Rivera pleads not guilty in fatal stabbing of Mollie Tibbetts
- Melting Bite specializes in both Indian street food and cake at Newbo City Market location
- Cedar River threatening to flood again
- After stint in Boston Bruins rookie camp, Marek Valach eyes improvement with Cedar Rapids RoughRiders
- Everybody's back, and Clear Creek Amana boys' cross country team is ascendant